Recombinant Adeno-Associated Virus (rAAV) Technology Pioneered by AskBio’s Dr. Jude Samulski is Key Component of All FDA Approved AAV Gene Therapeutics Asklepios BioPharmaceutical, Inc. (AskBio),…
Astellas, Seagen and Merck Announce FDA Acceptance of Supplemental Biologics License Applications for PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) for the First-Line Treatment of Certain…
New Results from the Phase 3 GLOW Study of Fixed-Duration Treatment with IMBRUVICA® (ibrutinib) Plus Venetoclax Demonstrate Robust Efficacy and Sustained Response in Older, Unfit Patients…
Despite continued impact of COVID-19, malaria cases and deaths remained stable in 2021 New data released today by the World Health Organization (WHO) show that…
The European Union and WHO further enhance their partnership for stronger pandemic preparedness and response the European Union’s Health Emergency Preparedness Authority (HERA) and the…
World Health Organization Director-General meets with KSrelief Supervisor General H.E Dr Abdullah Al Rabeeah World Health Organization Director-General Dr Tedros Adhanom Ghebreyesus met today at…
WHO Member States agree to develop zero draft of legally binding pandemic accord in early 2023 Member States of the World Health Organization today agreed…
European Medicines Agency Accepts Tofersen Marketing Authorization Application to Treat Rare, Genetic Form of ALS Biogen Inc. (Nasdaq: BIIB) announced the European Medicines Agency (EMA) has…
Lilly Announces Updated Data from the Verzenio® (abemaciclib) Phase 3 monarchE Trial Presented at SABCS and Simultaneously Published in The Lancet Oncology The benefit of…
Novartis Kisqali® prolonged PFS benefit for pre- and perimenopausal patients with aggressive HR+/HER2− metastatic breast cancer compared to chemotherapy Novartis announced results from the RIGHT…
Novartis Pluvicto™ shows statistically significant and clinically meaningful radiographic progression-free survival benefit in patients with PSMA–positive metastatic castration-resistant prostate cancer Novartis announced the pivotal Phase…
Bayer Launches Industry-First Public Database Listing Company’s Science Collaborations and Partnerships in the U.S. Bayer announced the U.S. launch of the Bayer Science Collaboration Explorer…